Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Elisa De Togni"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Graft-versus-host disease (GVHD) is a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). For many years, corticosteroids have been the mainstay treatment for GVHD, but cases of steroid-refrac
Externí odkaz:
https://doaj.org/article/4f8d7130a7ac45a0850f44778138ca30
Publikováno v:
Leukemia & Lymphoma. 63:2975-2981
Cytokine release syndrome (CRS) is a potentially fatal systemic inflammatory response that can occur in patients undergoing peripheral blood haploidentical hematopoietic cell transplantation (haplo-HCT). Severe CRS has previously been associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14934e0b7790aa8b1b2fc5b53526019b
https://doi.org/10.1080/10428194.2022.2100367
https://doi.org/10.1080/10428194.2022.2100367
Autor:
Hunter Cassidy Cochran, Michael Slade, Feng Gao, Sonia Godbole, Aaron Pruitt, Elisa De Togni, Aashray Singareddy, Chang Liu, Ramzi Abboud
Publikováno v:
Transplantation and Cellular Therapy. 28:S264-S265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36e98d0bdc96ce181a636c5054daa1b8
https://doi.org/10.1016/s2666-6367(22)00501-2
https://doi.org/10.1016/s2666-6367(22)00501-2
Autor:
Sonia Godbole, Feng Gao, Michael Slade, Elisa De Togni, Aaron Pruitt, Hunter Cassidy Cochran, Aashray Singareddy, Ramzi Abboud
Publikováno v:
Transplantation and Cellular Therapy. 28:S266-S267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b08b43714058153dabd2dc95253ce50
https://doi.org/10.1016/s2666-6367(22)00503-6
https://doi.org/10.1016/s2666-6367(22)00503-6
Autor:
Elisa De Togni, Mary C. Fulbright, Grant A. Challen, Hamza Celik, Marianna B. Ruzinova, Stephen T. Oh, Abigail J Wong, Angelo Brunelli Albertoni Laranjeira, Daniel A.C. Fisher, Tim Kong, Taylor B. Collins
Publikováno v:
Blood Advances
Key Points Pevonedistat targets the NFκB pathway to inhibit growth of MPN and sAML cells.Pevonedistat reduces disease burden in MPN mouse models.
Visual Abstract
Targeted inhibitors of JAK2 (eg ruxolitinib) often provide symptomatic relief
Visual Abstract
Targeted inhibitors of JAK2 (eg ruxolitinib) often provide symptomatic relief
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff881d98aa77152af9d1c0e8e80251a5
https://pubmed.ncbi.nlm.nih.gov/34644371
https://pubmed.ncbi.nlm.nih.gov/34644371
Autor:
Jennifer Y. Liu, Owen W. Peng, Alan Y. Lu, Alexander Kizhner, Ashley R. Gao, Mark C. Xu, Zita T. Chan, Kelly A. Hu, Elisa De Togni, Erica P. Ryu, Barrie Cascella, Sophia Shi, Luis A. Goicouria, Cynthia K. Holland, Erin M. Hall, Rebecca S. Yang, Maria L. Sorkin, Soon Goo Lee, Patricia L. Walker, Regina Liu, Grace Wang, Chris T. Edwards, Trenton J. Dawson, Katherine Huang, Andrew Z. Lin, Kaleena Zhang, Sheri A. McClerkin, Josephine S. Lee, Kelsie C. Kodama, Wilhelm Cruz, Barbara N. Kunkel, Joseph M. Jez, Isabel K. Eng
Publikováno v:
Bioscience Reports. 40
Aldehyde dehydrogenases (ALDHs) catalyze the conversion of various aliphatic and aromatic aldehydes into corresponding carboxylic acids. Traditionally considered as housekeeping enzymes, new biochemical roles are being identified for members of ALDH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7870a7d75c8cb3b0dc27ec7bbf38bd1d
https://doi.org/10.1042/bsr20202959
https://doi.org/10.1042/bsr20202959
Autor:
Aaron Pruitt, Michael Slade, Hunter Cochran, Feng Gao, Sonia Godbole, Elisa De Togni, Aaron Singareddy, Ramzi Abboud
Publikováno v:
Blood. 138:2924-2924
Introduction: Haploidentical hematopoietic cell transplantation (haplo-HCT) is an increasingly utilized therapy for a variety of hematologic malignancies. Determining which donor characteristics affect transplant outcomes is of particular interest in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::121e041eff473fdab3170ecd1395283a
https://doi.org/10.1182/blood-2021-149718
https://doi.org/10.1182/blood-2021-149718
Publikováno v:
Blood. 138:1800-1800
Introduction: Cytokine release syndrome (CRS) is a potentially fatal systemic inflammatory response that can occur in patients undergoing haploidentical hematopoietic cell transplantation (haplo-HCT). IL-6 inhibitors, such as tocilizumab, are effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::303d1590e107e73878b2ece6980c0a78
https://doi.org/10.1182/blood-2021-147103
https://doi.org/10.1182/blood-2021-147103
Autor:
Elisa De Togni, Julie Ritchey, Jessica Niswonger, Matthew L. Cooper, John F. DiPersio, Julie O'Neal, Miriam Y. Kim
Publikováno v:
Blood. 132:2205-2205
Chimeric antigen receptor (CAR) T cells are a novel therapeutic approach which have shown good clinical outcomes in patients receiving CD19 CAR T cells for B cell acute lymphoblastic leukemia. CAR T cells are made to express a CAR that recognizes a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c080d80684f753800c85c01f062ad45
https://doi.org/10.1182/blood-2018-99-113438
https://doi.org/10.1182/blood-2018-99-113438